Phase I/II Study of Combined Treatment with AT-101, Cisplatin and Radiotherapy in Patients with Locally Advanced Head and Neck Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 16 Feb 2013
At a glance
- Drugs AT 101 (Primary) ; Cisplatin
- Indications Head and neck cancer; Hypopharyngeal cancer; Oropharyngeal cancer
- Focus Adverse reactions
- 16 Feb 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 27 Jul 2011 New trial record